Time for management to resign, page-52

"It is not necessarily all negative. The objective is to get access to US funds and get the name [Mesoblast] on the radar. They do get $US68 million through the door."

Amateur hour? You missed the significance of this from the article and you still call MSB's listing amateur hour?

FGS...this is unreal. Sure there are some costs but if you can't see there is a strategy there, you shouldn't be in biotechs. Simple. We should all just bail out and feed the shorters!

Iltescu and the company have gone from world leaders in Stem cell therapy to amateurs with one throw away line in a chat room and some bad feeling because of a dip in the SP and some deals with the underwriters to maximise their returns.

There are plenty of Australian bios who have great science, a huge number shares on issue which forces consolidations (Smashing shareholder value by 1000% in some cases, just to stay afloat) and SP below 10c. They are so far away from a Nasdaq listing it's sad. Plus being listed lines you up for positive anns being received and acted on by people with cash.

It's amateur hour to even pretend that a successful listing on Nasdaq isn't an achievement. (It is).​